Gene therapy using lentiviral vectors was being explored in early stage trials as of 2009.[needs update] In a Phase I clinical trial of three patients... 11 KB (1,503 words) - 22:06, 10 December 2023 |
CAR T cell (redirect from CAR T-cell therapy) express a specific CAR, using a vector derived from an engineered lentivirus such as HIV (see Lentiviral vector in gene therapy). The CAR programs the T cells... 76 KB (8,019 words) - 21:29, 13 April 2024 |
onset of tumors in a mouse strain prone to tumors. Moreover, clinical trials that utilized lentiviral vectors to deliver gene therapy for the treatment... 32 KB (3,573 words) - 14:14, 24 January 2024 |
(2014). "Long-term safety and tolerability of Pro Savin, a lentiviral vector-based gene therapy for Parkinson's disease: A dose escalation, open-label, phase... 14 KB (1,819 words) - 05:17, 18 December 2023 |
organism. Gene delivery is a necessary step in gene therapy for the introduction or silencing of a gene to promote a therapeutic outcome in patients and... 24 KB (2,869 words) - 16:15, 28 August 2023 |
Lentivirus (redirect from Lentiviral) platelet-factor VIII, the gene that is mutated in human hemophilia. Lentiviral infection has advantages over other gene-therapy methods including high-efficiency... 15 KB (1,711 words) - 12:25, 11 December 2023 |
hosts, and extended gene expression. Lentiviral vectors have also shown promise. Among challenges to clinical translation of gene therapy are possible immune... 24 KB (2,918 words) - 05:14, 18 December 2023 |
Thalassemia (redirect from Gene therapy for thalassemia) Emmanuel (February 2016). "Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β – Gene". Human Gene Therapy. 27 (2): 148–165. doi:10... 59 KB (6,592 words) - 09:51, 5 April 2024 |